Page last updated: 2024-08-17

carbostyril and Adenoma Sebaceum

carbostyril has been researched along with Adenoma Sebaceum in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becker, AJ; Ben-Ari, Y; Bordey, A; Buhler, E; Bulteau, C; Burnashev, N; Cardoso, C; Delalande, O; Dorfmuller, G; Dulac, O; Gataullina, S; Goriounova, NA; Lozovaya, N; Milh, M; Minlebaev, M; Pallesi-Pocachard, E; Represa, A; Scavarda, D; Shityakov, S; Tsintsadze, T; Tsintsadze, V; Watrin, F1

Other Studies

1 other study(ies) available for carbostyril and Adenoma Sebaceum

ArticleYear
Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model.
    Nature communications, 2014, Aug-01, Volume: 5

    Topics: Action Potentials; Animals; Anticonvulsants; Disease Models, Animal; Electroencephalography; Epilepsy; Gene Expression Regulation; Heterozygote; Humans; Male; Mice; Mice, Transgenic; Microtomy; Neocortex; Patch-Clamp Techniques; Pyrazoles; Quinolones; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Tissue Culture Techniques; TOR Serine-Threonine Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins

2014